Lipid nanoparticle-delivered mRNA IL-12 remodels the tumor microenvironment to potentiate neoantigen cancer vaccine efficacy
Year: 2026
Type: article
Abstract: Personalized cancer vaccines (PCVs) targeting tumor-specific neoantigens have emerged as a promising strategy for cancer immunotherapy; however, their clinical efficacy remains limited by insufficient immunogenicity and inadequate remodeling of the tumor microenvironment (TME). To overcome these limitations, we investigated whether lipid nanoparticle (LNP)-based cytokine mRNA delivery could function as an immune modulator to enhance neoantigen vaccine efficacy. We evaluated the combinatorial effects of mRNA-based cytokines (GM-CSF, IL-12, and IL-15) with MHC class I- and class II-restricted neoantigen vaccines in a syngeneic MC38 colon cancer model. Following peritumoral administration, LNP-mediated mRNA delivery enabled localized cytokine expression, facilitating enhanced intratumoral immune activation while limiting systemic exposure. Among the candidates, mRNA-encoded IL-12 provided the greatest therapeutic benefit when combined with neoantigen vaccination, leading to robust tumor suppression and prolonged survival in both subcutaneous and peritoneal metastasis models. Mechanistically, IL-12 markedly enhanced MHC class II-restricted CD4⁺ T cell responses, as evidenced by increased IFN-γ and TNF-α production. Enhanced CD8⁺ T cell responses were also observed within the tumor microenvironment. These changes were accompanied by increased antigen-presenting cell activation, including dendritic cells and macrophages. Furthermore, IL-12-based combination therapy reshaped the TME by increasing tumor-infiltrating lymphocytes and effector T cells while reducing immunosuppressive regulatory T cells, thereby establishing a more immunostimulatory tumor milieu. Collectively, our findings demonstrate that LNP-mediated mRNA cytokine delivery enables effective in situ immune modulation, providing a biomaterial-based strategy to enhance neoantigen vaccine efficacy through controlled cytokine exposure and TME remodeling.
Source: Journal of Nanobiotechnology
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: lipid nanoparticle mRNA delivery, IL-12, personalized cancer vaccines, tumor microenvironment remodeling, cytokine mRNA, GM-CSF, IL-15, CD8+ T cells, dendritic cells, macrophages, regulatory T cells, tumor-infiltrating lymphocytes, colon cancer, peritumoral administration, peritoneal carcinomatosis, cancer immunotherapy
Open Access status: gold
Estimated APC paid: $3,790
Funder: Ministry of Food and Drug Safety
Award: G4570617725
OpenAlex ID: W7229603442
